Chunmei Bai

机构：Shanxi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0003-1333-9145

发表论文 255 篇 · 总被引 5845 次 · h-index 38

代表论文

• Research status and challenges of plant-derived exosome-like nanoparticles (2024 · Biomedicine & Pharmacotherapy · 被引 177)
• Preliminary activity and safety results of KRAS G12C inhibitor glecirasib (JAB-21822) in patients with pancreatic cancer and other solid tumors. (2024 · Journal of Clinical Oncology · 被引 36)
• Diagnostic efficacy of [68Ga]Ga-NY104 PET/CT to identify clear cell renal cell carcinoma (2024 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 33)
• Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma (2024 · International Immunopharmacology · 被引 24)
• Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China (2024 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 22)
• A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer. (2024 · Journal of Clinical Oncology · 被引 15)